Developmental dysplasia of the hip (DDH) occurs in infancy and comprises a broad spectrum of abnormalities, ranging from mild instability to dislocation. Dysplasia includes deformity of the acetabulum, the femoral head, or both: the acetabulum is too shallow, and the development of the femoral head is delayed, causing it to be smaller and aspherical. The exact mechanism of pathogenesis is not clear, but there seems to be a co-dependent system in which a normal shape of the acetabulum stimulates normal spherical development and central position of the femoral head, and vice versa.
Ultrasound of the neonatal hip plays a role in screening, diagnosis, and (monitoring of) treatment of DDH. This article reviews the epidemiology, static and dynamic ultrasound techniques in screening for DDH, and differences in screening programs throughout Europe.
The incidence of DDH varies from 1.5 to 20 per 1,000 births, depending on the criteria used for diagnosis and the population studied(1). In certain populations, a higher incidence of DDH was found due to cradling traditions: In the Navaho Indian tribes, in Japan, and in Turkey hips in newborns were tightly bound in extension and adduction, causing restricted motion of the hips and predisposing infants to DDH(2–4). At present, safe swaddling and carrying is advised, with hips in flexion and abduction(2,5).
Girls are two to seven times more likely to be affected by the condition than boys; 75–80% of affected infants are of the female sex(6–10). This is probably due to ligamentous laxity caused by maternal and fetal estrogens. Also, a higher number of estrogen receptors might play a role(11). In 60% of cases, DDH affects the left hip, since the most common left occiput anterior (LOA) position of the fetus in utero leaves the left leg with limited space for abduction. The left hip is pressed against the spine of the mother, which makes it less mobile. In 20% of cases, the right hip is affected, leaving another 20% of newborns with bilateral involvement(12,13). Besides female sex, the two strongest risk factors for developing DDH include breech position in utero and a positive family history(14,15). Breech position increases the risk of DDH by 2–24 times for both girls and boys(2,7–10,12,16). First-degree relatives (parent or sibling with DDH) increases the risk 12-fold(10,14,17,18).
Minor risk factors are widely mentioned but remain disputable. Most of the minor risk factors are related to limited space in utero, the so-called “packaging effects” among which are first born, oligohydramnios, high birth weight, and post maturity(12).
DDH is asymptomatic in infancy; however, when the child starts walking, symptoms emerge including limp, waddle, abnormal gait, and leg length discrepancy, which are mostly pain free. The average walking age is delayed by one month, which is clinically insignificant, since there is a wide variability in walking age and all are within the expected time(19). Late consequences of undetected DDH include pain and early osteoarthritis, frequently leading to premature hip replacement therapy.
Abnormalities in physical examination include limited hip abduction, leg length discrepancy, and thigh or buttock fold asymmetry(2). The most sensitive clinical test to detect hip instability is the Ortolani maneuver, in which abducting the infant’s hip causes the dislocated femoral head to relocate into the acetabulum with a palpable clunk(20,21).
Static ultrasound imaging of the newborns hips according to Graf’s method is widely performed(22,23). It is important to carry out this examination in a standardized and reproducible manner:
the bony acetabular rim,
the triradiate cartilage: a hypoechoic zone between the acetabulum, ischial bone and iliac bone, representing the deepest point of the acetabulum,
the center of the labrum.
Graf classification scale for developmental dysplasia of the hip
Type | Alpha angle | Acetabular modelling | Bony acetabular rim | Beta angle | Labrum | Position of femoral head | Age |
---|---|---|---|---|---|---|---|
|
>60° | good | sharp | <55° | good femoral coverage | central | all |
|
>60° | good | slightly rounded | <55° | good femoral coverage | central | all |
|
50–59° | deficient | rounded | <55° | coverage femoral head | central | <3 mo |
|
50–59° | deficient | rounded | <55° | coverage femoral head | central | >3 mo |
|
43–49° | severely deficient | rounded/flat | >55 but <77° | still coverage femoral head | stable or unstable | all |
|
43–49° | severely deficient | rounded/flat | >77° | still coverage femoral head | decentering | all |
|
<43° | poor | flat | labrum pressed upwards | eccentric | all | |
|
<43° | poor | flat | labrum pressed downwards/disappears | eccentric | all |
Different stages of abnormalities and their associated ultrasound findings are graded according to the Graf system and range from grade 1 (no dysplasia) to grade 4 (dislocation), as summarized in Tab. 2 (22). In a normal “mature” hip (Graf 1), the α-angle is higher than 60°, and the femoral head is located centrally in the acetabulum. In a Graf 2 hip, the α-angle is between 50 and 59°, and the femoral head is located centrally within the acetabulum. At ages below three months, a natural course in hip development may still show increasing α-angles, categorized as an immature hip (Graf 2A); after three months of age the slightly shallow acetabulum is due to a delay in development (Graf 2B). When the α-angle is between 43 and 49°, the hip can become unstable. If there is still a normal position of the cartilage labrum (β-angle <77°), this is referred to as Graf 2C dysplasia. In Graf D dysplasia, the hip is decentered; the cartilage labrum is pressed upwards, increasing the β-angle (>77°). In Graf 3 and 4 dysplasia, the α-angle is <43°, and the hips have an eccentric lateral position. In Graf 3, the labrum is pressed upwards because the subluxated femoral head pushes it away. In a Graf 4 situation, the femoral head is dislocated over the labrum; it is pushed down, or even disappears from the ultrasound field of view.
Example of standard report in ultrasound of DDH
Acetabular modelling: good/adequate/deficient/poor |
Bony acetabular rim: sharp/rounded/flat |
Alpha angle (°) |
Femoral head: ossification no/symmetric/asymmetric |
Femoral head position: centric – eccentric |
Beta angle (°) |
Probe positioning can substantially influence the measured α-angle, as shown in a recent publication by Jaremko
Difficulties in probe positioning in combination with multiple categories of the Graf classification can make the Graf method appear complex and confusing, especially for inexperienced radiographers. As an alternative to the angles, Morin
The morphology of the acetabulum and femoral head is best assessed at rest. When hip stability has to be evaluated, stress maneuvers with dynamic ultrasound can be performed. Two techniques described in the literature include lateral dynamic ultrasound (LDUS),(29) and anterior dynamic ultrasound (ADUS)(30). The most common application of LDUS in Europe is as an addition to static Graf imaging. Hips can be potentially unstable in Graf type 2C and more severe types of dysplasia; then dynamic US can be performed(22).
The dynamic LDUS examination is performed as follows: in the lateral/coronal transducer position with hip in flexion: 1.) observe while abducting and adducting the hip, and 2.) apply gentle stress to assess stability, while adducting the thigh (Barlow/posterior push maneuver). Examples of LDUS can be seen in Fig. 4. If the femoral head moves away from the posterior acetabulum with gentle stress, the hip is unstable. Furthermore, the percentage change in femoral head coverage with pressure can be analyzed.
It is important to realize that, when using the Graf classification, all hip joints are classified without stress provocation. For example, a Graf 2C hip that is unstable with dynamic imaging is classified as 2C unstable, not as a Graf D. Also, a Graf 3 hip that can be dislocated further with dynamic imaging is called a Graf 3, not a Graf 4(22).
ADUS is performed with a transinguinal probe position during the Barlow maneuver. This enables the operator to quantify (in millimeters) the movement of the hip within the acetabulum.
US can be used for screening purposes but also for monitoring active treatment in patients with dysplastic hips. The goal of DDH treatment is to obtain and maintain concentric reduction of the femoral head in the acetabulum. For infants younger than six months old, this can be managed by wearing an abduction (Pavlik) brace, with hips in flexion and abduction. After unsuccessful Pavlik treatment, a closed reduction of the femoral head into the acetabulum will be performed by the orthopedic surgeon. In our practice, we perform closed reductions under procedural sedation on the pediatric ward instead of general anesthesia in the operating room. After the radiologist has confirmed the proper position of the hip with transinguinal ultrasound, the hips are plastered in a spica cast(31–33). Regular follow-up in the cast is done by transinguinal ultrasound.
During transinguinal ultrasound, an axial image is obtained at the level of the pubic bone. In this view, the pubic bone and the femoral head should be in the same level (Fig. 5). If the hip is dislocated, the femoral head moves posteriorly and is no longer visualized in the expected level, so only the femoral neck is appreciated.
Screening for DDH is important, as the disease is occult at first, but may lead to serious disability on the long-term. Moreover, it is easily treated when detected at an early stage. For over 80 years, screening based on clinical examination has been highly recommended(20,21). Unfortunately, there is no international consensus concerning the application of ultrasound as a screening tool for DDH(34). There is no agreement as to whether one should perform ultrasound on all newborns (universal screening) or only on those with risk factors or clinical instability of the hip (selective screening)(34,35). Furthermore, the optimal timing of the ultrasound examination is not clear yet. This leads to considerable variation within Europe, as displayed in Tab. 3, predominantly based on differences in the incidence of DDH and organization of healthcare systems. In the German-speaking countries and Italy, universal ultrasound screening is performed at an early age. In the Netherlands, selective ultrasound screening is performed when the infant is three months old if risk factors are present, or earlier if there is clinical instability of the hips at a physical examination which is performed at one week, one month, and three months old at the children’s healthcare center(36). Although there is no consensus regarding the optimal timing in different screening programs, it is advisable not to perform screening ultrasound before six weeks (unless there is clinical dislocation), since physiological laxity due to maternal estrogens will resolve by six weeks of age(37).
Different screening programs across Europe for the detection of DDH in newborns
Country | Type of ultrasound screening | Timing (week) |
---|---|---|
|
selective | 12 |
|
selective | <12 |
|
selective | <4 |
|
selective | 6–8 |
|
universal | 4–12 |
|
universal | 1 6–8 |
|
universal | <5 |
|
universal | Risk factor + 1–2 Risk factor – 4–5 |
|
selective | 1–12 |
|
selective | 1 |
|
selective | <6 |
|
universal | Risk factor + 1–2 Risk factor – 6 |
|
universal | 1–12 |
|
selective | 6 |
|
selective | 6 |
* Information on different screening programs presented with help from Young club members of the European Society of Skeletal Radiology (ESSR)
Good-quality studies comparing different screening programs are scarce(34). Two studies from Austria and Germany showed a decrease in surgery rates and complications, and also in costs, since the introduction of universal ultrasound screening, when compared with no ultrasound screening at all.(38,39). There are three studies that compared universal versus selective ultrasound screening; all found no significant differences in early (subluxation/dislocation) or late (acetabular dysplasia degenerative changes at skeletal maturity) outcome measures(40–42). However, a lower rate of re-examinations and treatment in the selective screening group was described: treatment was necessary in 1.8%, versus 3.4% in the universal group(40,42). A Cochrane review on this topic failed to reveal any clear recommendations: for ethical reasons, there are no studies comparing ultrasound screening with no screening at all. Furthermore, the randomized controlled trials that were conducted were underpowered in the events of late DDH or surgery; preferably a follow-up of 50 years is needed.
Ultrasound screening for DDH is important, as the disease is initially occult, and easier to treat when identified early. There is no international consensus on the ultrasound screening for DDH specifying who should be selected for screening and at what age. This results in major differences in screening programs throughout Europe; mainly based on the incidence of DDH and healthcare system organization. All in all, despite the controversies described in this article, it can be stated that in the “best practice” screening programs ultrasound evaluation is used to prevent serious disability of the hip in the long-term.